PozeSCAF Inc Information

Summary

Transforming Drug Discovery through AxDrug & Synthesis Expertise

AxDrug, our state-of-the-art AI engine, revolutionizes the drug discovery landscape by swiftly identifying promising "hit"...Show more

Headquarters Location

Employees Size

10-50 employees

Specialties

small molecule discovery, AI, machine learning, molecular modeling, predictive toxicology, custom AI model, artificial intelligence, deep learning, de novo drug design, predictive modelling, QSAR studies, virtual screening, peptide screening, molecular dynamic simulations, computational peptide design, computational drug discovery, molecular docking, hit to lead, in silico, hit identification, lead optimisation, IND enabling studies, integrated drug discovery, target validation

Founded

2019